Thanks for emailing that article!
Recipients of the first six grants from the new Shaffer Fund for Innovative Glaucoma Research were announced January 23, 2008 at Glaucoma Research Foundation’s 30th Anniversary Benefit.
The Shaffer Grants continue our longstanding commitment to one-year incubation grants to explore novel or promising ideas in the study of glaucoma.
To date, we have awarded more than 120 Pilot Project grants. The 2008 Shaffer Fund research grants at $40,000 each were awarded to:
Paul Habib Artes, PhD
Dalhousie University, Halifax, NS, Canada
Analysis of Progression in Glaucoma
Jamie Craig, PhD
Genome-wide association in Primary open-angle Glaucoma: The Blindness in Glaucoma Genetic Epidemiology Relative Risk Study
Brad Fortune, OD, PhD
Devers Eye Institute, Portland, OR
Imaging the Course of Axonal Degeneration in Experimental Glaucoma
Kate E. Keller, PhD
Casey Eye Institute, Portland, OR
RNAi Gene Silencing of Enzymes in the Glycosaminoglycan Biosynthetic Pathway
Raquel L. Lieberman, PhD
Georgia Institute of Technology, Atlanta, GA
Development of Pharmacological Chaperone Therapy for Inherited Primary and Juvenile open-angle Glaucoma
Yutao Liu, MD, PhD
Duke University Medical Center, Durham, NC
Investigation of Gene Copy Number Variants in Primary Open-angle Glaucoma
Mark Filla, PhD (University of Wisconsin - Madison) was selected by the GRF Scientific Advisory Committee to receive the first annual Shaffer Prize for Innovative Glaucoma Research based on the results of his research funded by a 2006 Pilot Project. Dr. Filla’s research points the way to possible new therapies less likely to elicit side effects.
His research results were selected for publication in the July 2006 edition of Investigative Ophthalmology and Visual Science.
Last reviewed on October 29, 2017
This article appeared in the May 2008 issue of Gleams.Subscribe